Physician profile
Whitney Moose
NPI 1366892432
$2,955.25
in general payments reported to CMS, 2019-2025
23 companies · $49.59 in 2025
The $49.59 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $321 · 2022: $585 · 2023: $806 · 2024: $1,194 · 2025: $49.59.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,704 · Travel and Lodging: $255 · Education: $89.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,704.44 |
| Travel and Lodging | $255.15 |
| Education | $89.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $911.12 | 2021-2024 | Fasenra, Tezspire, Breztri |
| Inspire Medical Systems, INC. | $501.48 | 2023-2024 | Inspire |
| Glaxosmithkline, LLC. | $309.61 | 2021-2024 | Nucala, Arexvy, Trelegy Ellipta |
| United Therapeutics Corporation | $125.98 | 2024 | Tyvaso |
| Paratek Pharmaceuticals, INC. | $125.00 | 2023 | Nuzyra |
| Intuitive Surgical, INC. | $124.17 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $117.35 | 2024 | Uptravi, Opsumit |
| Baxter Healthcare | $98.55 | 2022-2023 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $93.98 | 2021-2024 | Spiriva Respimat, Stiolto Respimat |
| Mylan Specialty L.P. | $88.73 | 2023-2024 | Yupelri |
| Genzyme Corporation | $77.32 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $72.61 | 2024 | Glassia |
| Merz North America, INC. | $49.59 | 2025 | |
| Harmony Biosciences LLC | $45.95 | 2024 | |
| Electromed, INC. | $45.08 | 2023-2024 | Smartvest |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $40.98 | 2021-2024 | Tezspire |
| Inogen, INC. | $22.12 | 2022 | |
| Ani Pharmaceuticals, INC. | $22.04 | 2023 | Purified Cortrophin Gel |
| Grifols USA, LLC | $20.05 | 2024 | Prolastin-C Liquid |
| Philips North America LLC | $18.40 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $17.19 | 2024 | Dupixent |
| Insmed, INC. | $14.93 | 2024 | Arikayce |
| Advanced Respiratory, INC | $13.02 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Whitney Moose listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.